Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3

Journal of Endocrinology

Volumn 169, Issue 1, 2001, Pages 123-133

  Galanis, M ^a   Firth, S M ^a   Bond, J ^a   Nathanielsz, A ^a   Kortt, A A ^a   Hudson, P J ^a   Baxter, R C ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYSTEINE; HYBRID PROTEIN; MITOGENIC AGENT; PEPTIDE HORMONE; RECOMBINANT PROTEIN; REGULATOR PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

AMINO TERMINAL SEQUENCE; ANALYSIS; ARTICLE; ASSAY; BACTERIUM; BINDING AFFINITY; BINDING SITE; BIOSENSOR; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN STRUCTURE; SYNTHESIS;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; BIOSENSING TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECOMBINANT PROTEINS; SOMATOMEDINS;

EID: 0035069376     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1690123     Document Type: Article

References (39)

1. Towards identification of a binding site on insulin-like growth factor-II for IGF-binding proteins
2. Molecular aspects of insulin-like growth factor binding proteins
3. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
4. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum
5. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3
6. Site-directed mutagenesis of the N-terminal region of IGF binding protein 1; analysis of IGF binding capability
7. Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity
8. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3
9. Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3
10. Structural determinants of ligand and cell surface binding of insulin-like growth factor binding protein-3
11. Localisation of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain
12. Calculation of protein extinction coefficients from amino acid sequence data
13. Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit
14. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3
15. Characterization of truncated insulin-like growth factor-binding protein-2 in human milk
16. The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIGFBP-2) probed by iodination
17. Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding
18. Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the '150-K' complex during pregnancy
19. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions
20. Introducing a biosensor based technology for real-time biospecific interaction analysis
21. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions
22. Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilised receptors
23. Recombinant anti-sialidase single-chain variable fragment antibody: Characterisation, formation of dimer and higher-molecular-mass multimers fragment/sialidase complex
24. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: Effect of immobilisation level and flow rate on kinetic analysis
25. Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging
26. Structure-function analysis of the human insulin-like growth factor binding protein-4
27. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
28. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3)
29. A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3
30. Insulin-like growth factor (IGF) binding protein-5 forms an alternative ternary complex with IGFs and the acid-labile subunit
31. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain
32. A central domain binding site in insulin-like growth factor binding protein-5 for the the acid-labile subunit
33. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculorvirus expression and normal human urine
34. Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors
35. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins
36. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins
37. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF-I administration and in extrapancreatic tumor hypoglycemia
38. Active concentration measurements of recombinant biomolecules using biosensor technology